This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Lodz University of Technology, Peptaderm Sp. Z O.o., Other. Active years: 2016-2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 15 
1 out of 1 
1 out of 834,570 Years Active: 2016-2019
Title: Krzysztof Kaczmarek: Innovator in Cyclic Tetrapeptides
Introduction
Krzysztof Kaczmarek is a notable inventor based in Lodz, Poland. He has made significant contributions to the field of medicinal chemistry, particularly in the development of cyclic tetrapeptides. With a total of 2 patents, his work has implications for therapeutic applications.
Latest Patents
Kaczmarek's latest patents focus on cyclic tetrapeptides and their therapeutic applications. The patents detail compounds of formula I, which include various components defined in the application. These compounds have potential uses in medical treatments, showcasing Kaczmarek's innovative approach to drug development.
Career Highlights
Throughout his career, Kaczmarek has been associated with reputable institutions such as Lodz University of Technology and Peptaderm Sp. z o.o. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Kaczmarek has collaborated with esteemed colleagues, including Janusz Zabrocki and Michal Zimecki. These partnerships have enriched his research and fostered a collaborative environment for innovation.
Conclusion
Krzysztof Kaczmarek's contributions to the field of cyclic tetrapeptides highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing therapeutic applications in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile